Raymond A. Kemper
Vertex Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Carcinogens and Genotoxicity Assessment, Computational Drug Discovery Methods, Pharmacogenetics and Drug Metabolism, Alcohol Consumption and Health Effects, Per- and polyfluoroalkyl substances research
Most-Cited Works
- → Binding of Perfluorooctanoic Acid to Rat and Human Plasma Proteins(2003)400 cited
- → Refining the Human iPSC-Cardiomyocyte Arrhythmic Risk Assessment Model(2013)158 cited
- → Absorption, Distribution, Metabolism, and Elimination of 8-2 Fluorotelomer Alcohol in the Rat(2006)134 cited
- → Principles and procedures for implementation of ICH M7 recommended (Q)SAR analyses(2016)109 cited
- → Genetic toxicology in the 21st century: Reflections and future directions(2011)105 cited
- → Bacterial mutagenicity screening in the pharmaceutical industry(2012)70 cited
- → An in Silico Method for Predicting Ames Activities of Primary Aromatic Amines by Calculating the Stabilities of Nitrenium Ions(2010)70 cited
- → Understanding Genetic Toxicity Through Data Mining: The Process of Building Knowledge by Integrating Multiple Genetic Toxicity Databases(2008)47 cited
- → Subcellular Distribution and Protein Binding of Perfluorooctanoic Acid in Rat Liver and Kidney(2005)46 cited
- → Extending (Q)SARs to incorporate proprietary knowledge for regulatory purposes: A case study using aromatic amine mutagenicity(2016)46 cited